PEDEVCO Corp. (PED)
NYSEAMERICAN: PED · Real-Time Price · USD
0.6199
+0.0099 (1.62%)
Aug 8, 2025, 4:00 PM - Market closed
Ligand Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Ligand Pharmaceuticals stock has a target of 1.50, which predicts a 141.97% increase from the current stock price of 0.62.
Price Target: $1.50 (+141.97%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 20, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Ligand Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $1.5 | Strong Buy | Maintains | $1.5 | +141.97% | May 20, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $1.5 | Strong Buy | Maintains | $1.5 | +141.97% | Apr 2, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $1.5 | Strong Buy | Maintains | $1.5 | +141.97% | Mar 13, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $2.25 → $1.5 | Strong Buy | Maintains | $2.25 → $1.5 | +141.97% | Nov 20, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $1.75 | Strong Buy | Initiates | $1.75 | +182.30% | Jul 17, 2024 |
Financial Forecast
Revenue This Year
32.78M
from 39.55M
Decreased by -17.14%
Revenue Next Year
38.48M
from 32.78M
Increased by 17.41%
EPS This Year
0.06
from 0.20
Decreased by -69.60%
EPS Next Year
0.08
from 0.06
Increased by 33.33%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 34.3M | 40.0M |
| Avg | 32.8M | 38.5M |
| Low | 31.6M | 37.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | -13.2% | 22.1% |
| Avg | -17.1% | 17.4% |
| Low | -20.2% | 13.9% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.07 | 0.08 |
| Avg | 0.06 | 0.08 |
| Low | 0.05 | 0.08 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | -63.1% | 38.6% |
| Avg | -69.6% | 33.3% |
| Low | -75.4% | 29.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.